Control of ocular bleeding using clonidine derivatives

Details Control of ocular bleeding using clonidine derivatives Control of ocular bleeding using clonidine derivatives

1984-12-14

1986-05-06

Robinson, Douglas W.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

514912, A61K 31415

Patent

active

045872570

ABSTRACT:
A method of controlling anterior segment ocular bleeding is described. The method utilizes various clonidine derivatives (e.g., p-aminoclonidine) as the hemostatic agent.

REFERENCES:
patent: 3202660 (1965-08-01), Zeile et al.
patent: 3468887 (1969-09-01), Stahle et al.
patent: 3595961 (1971-07-01), Stahle et al.
patent: 3666861 (1972-05-01), Zaimis et al.
patent: 4166859 (1979-09-01), Stahle et al.
patent: 4213995 (1980-07-01), Stahle et al.
patent: 4461904 (1984-07-01), York
patent: 4515800 (1985-05-01), Cavero et al.
patent: 4517199 (1985-05-01), York
J. Med. Chem. 19(8), 1049-54, (1976)-Rouot et al.

Affiliated with

Also associated with

Rating

Control of ocular bleeding using clonidine derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Control of ocular bleeding using clonidine derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Control of ocular bleeding using clonidine derivatives will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1574812